For help on how to get the results you want, see our search tips.
1523 results
Medicine
Shortages Remove Shortages filter
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Summaries of opinion Remove Summaries of opinion filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Tecentriq (updated)
atezolizumab, Carcinoma, Transitional Cell, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 20/09/2017,
, Revision: 9, Authorised, Last updated: 13/07/2020
-
List item
Human medicine European public assessment report (EPAR): Dynastat (updated)
parecoxib sodium, Pain, Postoperative
Date of authorisation: 22/03/2002, Revision: 30, Authorised, Last updated: 13/07/2020 -
List item
Human medicine European public assessment report (EPAR): Mektovi (updated)
binimetinib, Melanoma
Date of authorisation: 20/09/2018,, Revision: 3, Authorised, Last updated: 13/07/2020
-
List item
Human medicine European public assessment report (EPAR): Kinzalkomb (updated)
telmisartan, hydrochlorothiazide, Hypertension
Date of authorisation: 19/04/2002, Revision: 36, Authorised, Last updated: 13/07/2020 -
List item
Human medicine European public assessment report (EPAR): Hopveus (updated)
sodium oxybate, Substance Withdrawal Syndrome, Alcohol Abstinence
Date of refusal: 06/07/2020, Refused, Last updated: 13/07/2020 -
List item
Human medicine European public assessment report (EPAR): Glivec (updated)
imatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Gastrointestinal Stromal Tumors, Dermatofibrosarcoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hypereosinophilic Syndrome
Date of authorisation: 07/11/2001,, Revision: 38, Authorised, Last updated: 13/07/2020
-
List item
Human medicine European public assessment report (EPAR): Zyclara (updated)
imiquimod, Keratosis, Keratosis, Actinic
Date of authorisation: 23/08/2012, Revision: 9, Authorised, Last updated: 13/07/2020 -
List item
Human medicine European public assessment report (EPAR): Verkazia (updated)
ciclosporin, Conjunctivitis, Keratitis
Date of authorisation: 06/07/2018,
, 
, Revision: 4, Authorised, Last updated: 10/07/2020
-
List item
Human medicine European public assessment report (EPAR): Truvada (updated)
emtricitabine, tenofovir disoproxil fumarate, HIV Infections
Date of authorisation: 20/02/2005, Revision: 42, Authorised, Last updated: 10/07/2020 -
List item
Human medicine European public assessment report (EPAR): Myfenax (updated)
mycophenolate mofetil, Graft Rejection
Date of authorisation: 21/02/2008,
, Revision: 22, Authorised, Last updated: 10/07/2020
-
List item
Human medicine European public assessment report (EPAR): Juluca (updated)
dolutegravir sodium, rilpivirine hydrochloride, HIV Infections
Date of authorisation: 16/05/2018,, Revision: 3, Authorised, Last updated: 10/07/2020
-
List item
Human medicine European public assessment report (EPAR): Aripiprazole Sandoz (updated)
aripiprazole, Schizophrenia, Bipolar Disorder
Date of authorisation: 20/08/2015,, Revision: 8, Authorised, Last updated: 10/07/2020
-
List item
Human medicine European public assessment report (EPAR): Darzalex (updated)
Daratumumab, Multiple Myeloma
Date of authorisation: 20/05/2016,, , , Revision: 12, Authorised, Last updated: 10/07/2020
-
List item
Human medicine European public assessment report (EPAR): Temozolomide Teva (updated)
temozolomide, Glioma, Glioblastoma
Date of authorisation: 28/01/2010,, Revision: 19, Authorised, Last updated: 10/07/2020
-
List item
Human medicine European public assessment report (EPAR): Nexium Control (updated)
esomeprazole, Gastroesophageal Reflux
Date of authorisation: 26/08/2013, Revision: 13, Authorised, Last updated: 10/07/2020 -
List item
Human medicine European public assessment report (EPAR): MicardisPlus (updated)
telmisartan, hydrochlorothiazide, Hypertension
Date of authorisation: 19/04/2002, Revision: 29, Authorised, Last updated: 10/07/2020 -
List item
Human medicine European public assessment report (EPAR): Olanzapine Glenmark Europe (updated)
olanzapine, Schizophrenia, Bipolar Disorder
Date of authorisation: 03/12/2009,, Revision: 13, Authorised, Last updated: 09/07/2020
-
List item
Human medicine European public assessment report (EPAR): Trazimera (updated)
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 26/07/2018,, 
, Revision: 6, Authorised, Last updated: 09/07/2020
-
List item
Human medicine European public assessment report (EPAR): Halaven (updated)
Eribulin, Breast Neoplasms, Liposarcoma
Date of authorisation: 17/03/2011, Revision: 21, Authorised, Last updated: 09/07/2020 -
List item
Human medicine European public assessment report (EPAR): Targretin (updated)
bexarotene, Lymphoma, T-Cell, Cutaneous
Date of authorisation: 29/03/2001, Revision: 20, Authorised, Last updated: 09/07/2020 -
List item
Human medicine European public assessment report (EPAR): Benlysta (updated)
belimumab, Lupus Erythematosus, Systemic
Date of authorisation: 13/07/2011,, Revision: 21, Authorised, Last updated: 09/07/2020
-
List item
Human medicine European public assessment report (EPAR): Trajenta (updated)
linagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 23/08/2011, Revision: 16, Authorised, Last updated: 09/07/2020 -
List item
Human medicine European public assessment report (EPAR): Actelsar HCT (updated)
telmisartan, hydrochlorothiazide,
Date of authorisation: 13/03/2013,, Revision: 10, Authorised, Last updated: 09/07/2020
-
List item
Human medicine European public assessment report (EPAR): Dovato (updated)
dolutegravir sodium, lamivudine, HIV Infections
Date of authorisation: 01/07/2019, Revision: 3, Authorised, Last updated: 09/07/2020 -
List item
Human medicine European public assessment report (EPAR): Trogarzo (updated)
Ibalizumab, HIV Infections
Date of authorisation: 26/09/2019,, Revision: 2, Authorised, Last updated: 09/07/2020